HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

2- (4- (quinolin- 2- yl- methoxy)phenyl)- 2- cyclopentylacetic acid

inhibits synthesis of leukotriene B4 and 5-hydroxyeicosatetraenoic acid; inhibits five-lipoxygenase activating protein(FLAP)and leukotriene A4 hydrolase(LTA4H); structure given in first source;
Also Known As:
BAYX-1005; Bay X 1005; Bay X1005; Bay-X1005; DG-031; Veliflapon; Benzeneacetic acid, alpha-cyclopentyl-4-(2-quinolinylmethoxy)-, (R)-
Networked: 10 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Korbut, R: 1 article (09/2007)
2. JawieĊ„, J: 1 article (09/2007)
3. Gajda, M: 1 article (09/2007)
4. Olszanecki, R: 1 article (09/2007)
5. Boileau, C: 1 article (06/2005)
6. Fahmi, H: 1 article (06/2005)
7. Lavigne, M: 1 article (06/2005)
8. Martel-Pelletier, J: 1 article (06/2005)
9. Tardif, G: 1 article (06/2005)
10. Pelletier, J-P: 1 article (06/2005)

Related Diseases

1. Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
2. Psoriasis (Pustulosis Palmaris et Plantaris)
3. Eosinophilia
4. Asthma (Bronchial Asthma)
5. Rheumatoid Arthritis

Related Drugs and Biologics

1. Leukotrienes
2. Antigens
3. Acetylcholine (Acetylcholine Chloride)
4. zileuton (Zyflo)
5. zafirlukast (Accolate)
6. Arachidonic Acid (Vitamin F)
7. licofelone
8. N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamide
9. 5-Lipoxygenase-Activating Proteins
10. Interleukin-1beta (Interleukin 1 beta)

Related Therapies and Procedures

1. Oral Administration